Guwahati, 29/4: IIT Guwahati joined hands with Ahmedabad-based pharmaceutical firm Hester Biosciences on Wednesday to develop a vaccine to fight against the deadly Coronavirus. The vaccine will be based on recombinant avian paramyxovirus.
“IITG and Hester have collaborated to develop and manufacture a recombinant vaccine against COVID-19 diseases as a preventive measure. Hester’s involvement would be from the master seed development up to the release of the commercial vaccine” Rajiv Gandhi CEO MD Hester BioScience said.